B-LCL-HROM01 Cells
1 104,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | The cell line was derived from the peripheral blood of a patient with CRC. |
|---|---|
| Organisme | Human |
| Tissu | Peripheral blood |
| Maladie | Carcinoma |
| Site métastatique | Not applicable (EBV-transformed B-LCL from CRC patient; suspension culture) |
| Applications | T cell and NK cell assays; HLA typing; antigen presentation studies; CTL assay target cells; colorectal cancer immunology; HROM01 patient-matched biobank studies |
| Synonymes | TiBc HROM |
Caractéristiques
| Âge | Age unspecified |
|---|---|
| Genre | Sex unspecified |
| Origine ethnique | Caucasian |
| Morphologie | Round cells |
| Type de cellule | B lymphoblast |
| Propriétés de croissance | Suspension |
Données réglementaires
| Référence | B-LCL-HROM01 (Cytion catalog number 302079) |
|---|---|
| Niveau de biosécurité | 2 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | Not assigned |
| Statut OGM | GMO-S2: This B-LCL contains a stably maintained EBV episome (EBNA-1/-2/-3, LMP-1/-2). EBV is classified as risk group 2; BSL-2 containment required. This classification applies within Germany; regulations may differ elsewhere. |
Données biomoléculaires
| Virus | Transformant: EBV |
|---|
Manipulation
| Milieu de culture | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suppléments | Supplement the medium with 10% heat-inactivated FBS |
| Temps de doublement | 24 to 48 hours |
| Repiquage | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
| Rapport de fractionnement | 1 to 4 |
| Densité de semis | 2 to 5 × 10⁵ cells/ml |
| Renouvellement des fluides | Every 2 to 3 days |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|